Royal Bournemouth Hospital
Bournemouth, Dorset BH7 7DW
1 studies enrolling now · 12 studies all time
What they study most
Cardiovascular Diseases, Coronary Artery Disease, Coronary Disease, HIV Infection, Heart Diseases, Heart Failure, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, MDS, Multiple Myeloma, Myelodysplastic Syndrome, Myocardial Ischemia
Studies at this site
- MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers — Completed
- Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
- Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
- Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
- Strategic Timing of Antiretroviral Treatment — Completed
- A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT) — Completed
- International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
- A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
- Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early
- Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia — Completed